VISIOMED GROUP (ALVMG.PA)

Company Profile

Visiomed Group SA engages in the development and distribution of healthcare products and services. The company is headquartered in Paris, Ile-De-France and currently employs 73 full-time employees. The company went IPO on 2011-07-05. The firm is primarily engaged in the design, manufacture and marketing of medical electronics. The company develops and markets health products in the fields of medical and well-being self-diagnosis to provide non-drug prevention and treatment solutions. The firm's product portfolio comprises MyThermo, an infrared contact-less medical thermometer; MyTension, an automatic blood pressure and pulse monitors; MyOxy, a finger pulse oximeter; MyECG, a pocket electrodiogram; MyGluco, a blood sugar meter; My Coach, a health and fitness coach, and Epiderm, a telemedicine dermatology mobile application, among others. The firm serves pharmacies, health professionals, hospitals, clinics and retirement homes. The company also offers connected solutions and COVID devices such as deconfinement kits, masks, filter cushion, serological tests etc. The Company’s subsidiaries include ThermoFlash and BewellConnect.

Company Info

VISIOMED GROUP

74 rue Blanche

Paris ILE-DE-FRANCE

P: 33180272990

Employees: 73

Website: https://www.visiomed-group.com/